Ultrasound test to predict treatment response in stomach cancer liver spread
Part of Cancer, Digestive system clinical trials.
This trial uses a special ultrasound technique to see if it can predict how well your stomach cancer that has spread to the liver will respond to the first treatment you receive. The goal is to help doctors choose the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with stomach cancer that has spread to the liver, and you have not had any treatment for it yet.
- The liver tumor is 6 cm or smaller and is located near large blood vessels or bile ducts, and is not too deep for ultrasound.
- You are planning to start standard first-line systemic therapy (like chemotherapy or targeted drugs).
- You have not had any prior treatment for this liver tumor, including surgery, ablation, embolization, or targeted therapy.
- You are willing to give written consent and can cooperate with the ultrasound exam.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound technique to see if it can predict early how well your cancer treatment will work on liver tumors that started in the colon or rectum. It uses special sound waves to measure pressure inside the tumor, which might help doctors adjust treatment sooner.
This trial tests a combination of three drugs — an immunotherapy (sintilimab), a targeted therapy (bevacizumab), and chemotherapy — for a specific type of stomach cancer that produces high AFP and has spread to the liver. The goal is to see if this treatment can shrink tumors enough to make them removable by surgery.
This study tests whether a special 3D ultrasound scan (using contrast) can help support decisions for people with colorectal cancer that has spread to the liver. If you have planned new cancer treatment, the scan may add information to help doctors guide care.
This trial uses advanced imaging (ultrasound and CT) plus a blood test to predict how well your stomach cancer will respond to chemotherapy given before surgery. The goal is to personalize your treatment and improve outcomes.
This study is testing a new way to use ultrasound to help treat colorectal cancer that has spread to the liver. It may help doctors see how tumors respond to treatment.
This study follows patients with stomach cancer that has spread to the liver to learn more about their health over time. It may help doctors understand how to better care for people with this condition.
Hear when a new Liver Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.